Keros Therapeutics Inc（KROS）價格預測KROSKeros Therapeutics Inc

Alphio's KROS stock price prediction model matches the current Keros Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.36 (-0.58%). The 1-week path is $11.54 (+0.98%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Keros Therapeutics Inc is a good buy right now due to its current price of $11.28, which is significantly below the analyst price targets of $17 and $18 from BofA and Wells Fargo, respectively. The company has a strong gross margin of 100% and is implementing a $5 million share repurchase program, indicating confidence in its stock value. However, a key risk is its forward P/E of 48.78, suggesting high expectations for future earnings that may not be met.

Keros Therapeutics Inc (KROS) last closed at $11.4250002, gaining +0.84%. These facts feed the 1-day and 1-week KROS price prediction above.